Search Results for: multiple sclerosis

Patient’s Powerful Story on Multiple sclerosis and Getting Experimental Stem Cells

Caroline-Wyatt

Multiple sclerosis (MS) can be an extremely debilitating disease that ultimately is fatal in some patients and reduces life expectancy and quality overall substantially. An MS patient named Caroline Wyatt, who works at the BBC, had the courage to open up in full detail on the BBC about having MS, her experience getting an experimental […]

Patient’s Powerful Story on Multiple sclerosis and Getting Experimental Stem Cells Read More »

Landmark New Stem Cell Trial for Multiple Sclerosis Raises Hopes

Mark-S.-Freedman

A new stem cell clinical trial for Multiple Sclerosis (MS) in Canada is raising hopes amongst patients and researchers. According to the Ottawa Citizen, the trial will be led by Dr. Mark S. Freedman (pictured, photo from Ottawa Hospital), director of the multiple sclerosis research unit at The Ottawa Hospital and “The Canadian trials which

Landmark New Stem Cell Trial for Multiple Sclerosis Raises Hopes Read More »

ACT patent filing for MSCs: of Dancing Mice & Multiple Sclerosis

dancing-mice

Is Advanced Cell Technology (ACT) on the road to cure Multiple Sclerosis (MS) using stem cells and specifically MSCs? Some folks seem to think it’s quite possible, but I remain skeptical. Still there have been some interesting developments. ACT has a relatively new patent filing for a mesenchymal stromal cell (MSC) product that was just

ACT patent filing for MSCs: of Dancing Mice & Multiple Sclerosis Read More »

Stem cell treatments for multiple sclerosis: where do things stand?

Symptoms_of_multiple_sclerosis.svg_

Where do things stand on the potential of stem cell treatments for multiple sclerosis (MS)? MS is an often devastating autoimmune disease in which the immune system attacks its own nervous system. More info can be found at the National MS website here. MS is a very serious health problem globally as about 400,000 people

Stem cell treatments for multiple sclerosis: where do things stand? Read More »

Weekly reads: stem cell therapy for vision loss, cancer self-experimentation, Slovenia, 14-day rule

limbal stem cell deficiency LSCD, stem cell therapy for vision loss

Is there a proven stem cell therapy for vision loss? When I started The Niche back in early 2010, one major area of hope was that there might one day be a stem cell therapy for vision loss or even blindness. Maybe even a cure for blindness. While we’re not there yet as a field,

Weekly reads: stem cell therapy for vision loss, cancer self-experimentation, Slovenia, 14-day rule Read More »

Weekly reads: Rusty Gage & stem cell awards, ASCL1, stem cells for a vulture

Rusty Gage

There should be more stem cell awards. Why not recognize more scientists and advocates? I used to do a Stem Cell Person of the Year Award. I have thought about bringing it back. What do you think? Scroll through some past posts on the Stem Cell Person of the Year Award. ISSCR gives out stem

Weekly reads: Rusty Gage & stem cell awards, ASCL1, stem cells for a vulture Read More »

Weekly reads: Vertex, stem cells for MS, Athersys, 900-day paper review at Nature

“While still early, these results support the continued progression of our VX-880 clinical studies, as well as future studies using our encapsulated islet cells, which hold the potential to be used without the need for immunosuppression,” said Bastiano Sanna, Ph.D., executive vice president and chief of cell and genetic therapies at Vertex.

Vertex Pharmaceuticals has a lot going for it right now on the cell therapy front. For instance, they have the strongest type 1 diabetes cell therapy pipeline after some recent acquisitions. Still it’s not a simple matter to succeed in the cell therapy space even with one therapy for one targeted disease. Trials are tough

Weekly reads: Vertex, stem cells for MS, Athersys, 900-day paper review at Nature Read More »

Weekly reads: Vertex & CRISPR Therapeutics, Arnold Caplan death, MS genetics

CRISPR Therapeutics

The biotechs Vertex and CRISPR Therapeutics have an interesting relationship as biotechs. They are partners are multiple levels but also are very different as companies including in size. There’s been a key development in one of their partnerships. Before we jump into that, please check out the video version of my 20 stem cell and

Weekly reads: Vertex & CRISPR Therapeutics, Arnold Caplan death, MS genetics Read More »

Weekly reads: stem cells for MS, good news x2, extending dog years, Neuralink updates

stem cells for MS

For about as long as I’ve been writing The Niche, people have been asking about stem cells for MS. There’s a huge need for new therapies. While a chemo-based approach with autologous hematopoietic stem cell transplantation (HSCT) looks to work for certain cases of multiple sclerosis (although not yet approved in the US), other cell

Weekly reads: stem cells for MS, good news x2, extending dog years, Neuralink updates Read More »